N/A
Completed N=345
Prevalence of Genital HPV Infection in Males Following Introduction of Universal Male HPV Vaccination
Source: ClinicalTrials.gov NCT02003508 ↗Enrolled (actual)
345
Serious AEs
0.0%
Results posted
Mar 2020
Primary outcomePrimary: Prevalence of Penile HPV Genotypes — 2.6; 0.7; 21.7; 11.6 percentage of participants
Summary
This study will examine how common HPV infection is in teenage males in Australia before and after the introduction of universal school based vaccination of males in Australia.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Prevalence of Penile HPV Genotypes |
2.6; 0.7; 21.7; 11.6; 15.1; 7.5 | — |
Eligibility Criteria
Inclusion Criteria
- Male
- Aged 17 to 19
- Able to complete study requirements
- Residing in Australia from 12 years of age
Exclusion Criteria
-Males reporting sex with males in the past 12 months
Data sourced from ClinicalTrials.gov (NCT02003508). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.